Koh Abe
Impact in
- Microbiology top 10%
- Antimicrobial Peptides and Activities
-
- Cardiovascular Health and Disease Prevention
Papers in
-
- Cystic Fibrosis Research Advances 5
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 4
- Vasculitis and related conditions 2
-
- Sarcoidosis and Beryllium Toxicity Research 2
- Smoking Behavior and Cessation 1
- Co-authors
- Shigeru Kohno (15 shared papers)Jun‐ichi Kadota (9 shared papers)Ryo Shirai (6 shared papers)Hiroshi Mukae (9 shared papers)Kaoru Kawakami (5 shared papers)Koichiro Kadota (5 shared papers)Fuminao Takeshima (6 shared papers)Osamu Sakito (2 shared papers)
- Journals
- Respiration (3 papers)Respiratory Medicine (1 paper)European Journal of Dermatology (1 paper)Antimicrobial Agents and Chemotherapy (1 paper)Journal of Clinical Gastroenterology (1 paper)
- Partner nations
- Japan
In The Last Decade
Koh Abe
21 papers receiving 386 citations
Peers
Comparison fields: 5 of 64
- Microbiology 32
- Cardiology and Cardiovascular Medicine 86
- Physiology 63
- Pulmonary and Respiratory Medicine 74
- Immunology 40
Countries citing papers authored by Koh Abe
This map shows the geographic impact of Koh Abe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koh Abe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koh Abe more than expected).
Fields of papers citing papers by Koh Abe
This network shows the impact of papers produced by Koh Abe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koh Abe. The network helps show where Koh Abe may publish in the future.
Co-authors
The 25 scholars most cited alongside Koh Abe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 100 | |
| 2 | 1999 | 52 | |
| 3 | 2009 | 52 | |
| 4 | Elevated serum beta-defensins concentrations in patients with lung cancer. | 2005 | 42 |
| 5 | 2000 | 26 | |
| 6 | 2005 | 22 | |
| 7 | 2004 | 18 | |
| 8 | 1994 | 16 | |
| 9 | 2010 | 16 | |
| 10 | 1998 | 14 | |
| 11 | 2003 | 7 | |
| 12 | 2013 | 7 | |
| 13 | 2021 | 7 | |
| 14 | 2007 | 6 | |
| 15 | 1997 | 5 | |
| 16 | 2010 | 5 | |
| 17 | [A case of non-specific interstitial pneumonia associated with psoriasis vulgaris and polymyalgia rheumatica]. | 1997 | 4 |
| 18 | [Case of nonspecific interstitial pneumonia associated with aortitis syndrome]. | 2008 | 3 |
| 19 | GLD Detector Outline Document: Version 1.2 | 2006 | 1 |
| 20 | 2012 | 1 |
About Koh Abe
Koh Abe is a scholar working on Pulmonary and Respiratory Medicine, Physiology, Gastroenterology, Immunology and Oncology, having authored 27 papers that have together received 405 indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (5 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers), Vasculitis and related conditions (2 papers), Lung Cancer Research Studies (2 papers), Sarcoidosis and Beryllium Toxicity Research (2 papers), Antimicrobial Peptides and Activities (1 paper), Smoking Behavior and Cessation (1 paper) and Particle Detector Development and Performance (1 paper). The work is most often cited by research in Microbiology (32 citations), Cardiology and Cardiovascular Medicine (86 citations), Physiology (63 citations), Pulmonary and Respiratory Medicine (74 citations) and Immunology (40 citations). Koh Abe has collaborated with scholars based in Japan. Frequent co-authors include Shigeru Kohno, Jun‐ichi Kadota, Ryo Shirai, Hiroshi Mukae, Kaoru Kawakami, Koichiro Kadota, Fuminao Takeshima, Osamu Sakito, Yoshiyuki Ozono and Jun-ichi Ashitani. Their work appears in journals such as Respiration, Respiratory Medicine, European Journal of Dermatology, Antimicrobial Agents and Chemotherapy and Journal of Clinical Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.